Abbott Labs stock rating reiterated at Buy by Benchmark on strong device sales
PositiveFinancial Markets

Abbott Labs has received a 'Buy' rating from Benchmark, highlighting the company's strong device sales. This endorsement reflects confidence in Abbott's growth potential and market performance, making it a noteworthy investment opportunity for shareholders. As the demand for medical devices continues to rise, Abbott's solid sales figures position it favorably in the competitive healthcare sector.
— Curated by the World Pulse Now AI Editorial System